Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Gemini Therapeutics Inc (GMTX) Stock Forecast 2025 - AI Price Prediction & Analysis

Gemini Therapeutics Inc (GMTX) AI Stock Price Forecast & Investment Analysis

Gemini Therapeutics Inc Stock Price Chart and Technical Analysis

Loading Gemini Therapeutics Inc interactive price chart and technical analysis...

Gemini Therapeutics Inc (GMTX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Gemini Therapeutics Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Gemini Therapeutics Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Gemini Therapeutics Inc: Gemini Therapeutics Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

Gemini Therapeutics Inc (Stock Symbol: GMTX) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 29 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Gemini Therapeutics Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Gemini Therapeutics Inc: With $1088M in annual revenue and 11.2% net margin, the company demonstrates solid profitability.

Annual Revenue: $1088 million generating a 11.2% net profit margin .

Market Capitalization: $831 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -48.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Gemini Therapeutics Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Gemini Therapeutics Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Gemini Therapeutics Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Gemini Therapeutics Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Gemini Therapeutics Inc: Market positioning analysis based on available financial and operational metrics.

Gemini Therapeutics Inc strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 25.2% gross margin, indicating strong pricing power and operational efficiency.

Gemini Therapeutics Inc (GMTX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Gemini Therapeutics Inc stock analysis.

Loading Gemini Therapeutics Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Gemini Therapeutics Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Gemini Therapeutics Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Gemini Therapeutics Inc: With a P/E ratio of -1.03, the market sees the stock as potentially undervalued.

P/E Ratio -1.03x
P/B Ratio 7.95x
Market Cap $831M
Dividend Yield 7.91%
EPS $-1.54
Book Value/Share $2.41
Revenue/Share $28.63
FCF/Share $4.49
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Gemini Therapeutics Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Gemini Therapeutics Inc: An ROE of -48.1% indicates room for improvement in shareholder value creation.

ROE -48.1%
ROA -43.4%
ROIC -46.4%
Gross Margin 25.2%
Operating Margin 11.8%
Net Margin 11.2%
EBT Margin 12.4%
Tax Rate 9.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Gemini Therapeutics Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Gemini Therapeutics Inc: A current ratio of 9.79 indicates strong liquidity.

Current Ratio 9.79x
Quick Ratio 9.39x
D/E Ratio 0.26x
Financial Leverage 1.11x
Interest Coverage -180.0x
Working Capital $451M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Gemini Therapeutics Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Gemini Therapeutics Inc: Free cash flow of $-61M indicates cash challenges that need attention.

Operating Cash Flow $-61M
Free Cash Flow $-61M
OCF Growth YoY 27.9%
FCF Growth YoY 62.2%
FCF/Sales 14.2%
CapEx/Sales 2.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Gemini Therapeutics Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Gemini Therapeutics Inc: An asset turnover of 0.77x suggests room for improvement in asset utilization.

Asset Turnover 0.77x
Receivables Turnover 4.6x
Inventory Turnover 6.4x
Fixed Assets Turnover 4.8x
Days Sales Outstanding 79 days
Days Inventory 57 days
Payables Period 44 days
Cash Conversion Cycle 92 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Gemini Therapeutics Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Gemini Therapeutics Inc: With annual revenue of $1088M, Gemini Therapeutics Inc operates at significant scale.

Income Statement ($ Millions)
Total Revenue $1088M
Operating Income $-43M
Net Income $-39M
R&D Expense $25M
SG&A Expense $12M
Cost of Goods Sold $75M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 100%
Cash & Short-term Investments 96%
Total Liabilities 10%
Short-term Debt 3%
Accounts Receivable 20%
Inventory 8%
Dividend & Shareholder Information
Dividends Per Share $0.44
Payout Ratio 13.7%
Shares Outstanding 43M

Latest Gemini Therapeutics Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Gemini Therapeutics Inc (GMTX) stock price and investment outlook.

📰 We are currently updating our news feed for Gemini Therapeutics Inc. Check back soon for the latest market analysis and company updates.

Gemini Therapeutics Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Gemini Therapeutics Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Gemini Therapeutics Inc Stock Forecast

How accurate are Gemini Therapeutics Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for GMTX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Gemini Therapeutics Inc stock price forecasts?

Our analysis considers Gemini Therapeutics Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Gemini Therapeutics Inc a good investment in 2025?

Based on our AI analysis, Gemini Therapeutics Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Gemini Therapeutics Inc forecasts updated?

Gemini Therapeutics Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Gemini Therapeutics Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Gemini Therapeutics Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...